© Siemens

At Siemens Healthineers, the portfolio effects resulting from the acquisition of Varian supported the growth in order intake by 21% and sales by 18%. The Diagnostics business was particularly profitable due to the volume of rapid coronavirus antigen tests and higher test volumes for routine examinations.